annb0t
Top 20
ResMed (RMD) reported $1.12 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 22.7%. EPS of $1.60 for the same period compares to $1.49 a year ago.
The reported revenue represents a surprise of +0.36% over the Zacks Consensus Estimate of $1.12 billion. With the consensus EPS estimate being $1.67, the EPS surprise was -4.19%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to de...
>>> Read more: Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics
The reported revenue represents a surprise of +0.36% over the Zacks Consensus Estimate of $1.12 billion. With the consensus EPS estimate being $1.67, the EPS surprise was -4.19%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to de...
>>> Read more: Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics
